Wilson James N

Wilson James N is listed in filings as Director at Corcept Therapeutics Incorporated. This profile follows SEC Form 4 activity through May 29, 2026, including 14 public disclosures. Recent filings connect the profile to Corcept Therapeutics Incorporated (CORT). The current snapshot covers public activity from Jun 12, 2025 to May 29, 2026. Reported amounts are shown as $746.1K to $1.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.